Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Yes, these medications are approved for weight loss in individuals without diabetes
Tirzepatide (dual GLP-1/GIP receptor agonist): In the SURMOUNT-1 trial, participants on the highest tirzepatide dose (15 mg) achieved approximately 22.5% body weight reduction at 72 weeks
Aggregated peptides lose biological activity and can trigger immune responses if administered
Your dose may need to go up as you progress through your treatment plan, but your monthly cost stays the same across all tiersensuring long-term affordability whether you use 0.5mg or 2.4mg weekly
You should avoid it if you: Have a personal or family history of medullary thyroid carcinoma
US$ 26.80
US$ 29.72
US$ 20.28
US$ 24.81
US$ 22.62
